Gerard Ryan, an attorney at the national law firm of Parker Waichman LLP, discusses recent safety concerns over Yaz, Yasmin and the risk of deep vein thrombosis, or DVT. The condition, which is defined as a blood clot forming in the deep veins of the body (typically the legs) has been linked to the new generation of oral contraceptives containing drospirenone. Yaz and Yasmin are the subject of thousands of lawsuits in the US claiming that the birth control pills caused DVT, which can lead to potentially fatal complications.
Yaz and Yasmin contain drospirenone, which is a synthetic version of the female hormone progestin. Drospirenone is a diuretic, meaning that it forces the body to excrete excess water. For this reason, some researchers believe that this increases the risk of deep vein thrombosis and other blood clot-related conditions. DVT can lead to serious, even fatal consequences in some patients. If part of the clot breaks away from its original location, it can travel through the bloodstream into the lungs; this is known as a pulmonary embolism. There is also a chance that the clot can travel to other vital organs, including the brain and heart.